Recent News

• 02.13.2025 - Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
• 02.13.2025 - Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow
• 01.13.2025 - Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
• 01.13.2025 - Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
• 01.08.2025 - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
• 01.08.2025 - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
• 01.08.2025 - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
• 01.08.2025 - Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues
• 01.06.2025 - Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 01.06.2025 - Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

• 01.23.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.08.2025 - EX-99.1 EX-99.1
• 01.08.2025 - 8-K Current report
• 01.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.06.2025 - EX-99.1 EX-99.1
• 12.16.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]